Abstract
This study was conducted to delineate the frequency of recurrent lupus nephritis in a Chinese kidney transplant cohort and to estimate its impact on long-term transplant outcomes. A total of 32 lupus transplant patients were enrolled in this study, and the medical records were retrospectively reviewed. Patients with unexplained graft abnormalities were subjected to allograft biopsy. Recurrent lupus nephritis was diagnosed by light microscopy, immunofluorescence, and electron microscopy. In addition, to determine the clinical manifestations of recurrent lupus GN in these patients, serum original systemic lupus erythematosus disease activity index (SLEDAI) scores while undergoing allograft biopsy were evaluated. In total, six out of 32 patients (18.8%; mean age, 40.5 ± 9.1 years) were diagnosed as having recurrent lupus nephritis and the mean time at diagnosis was 5.1 ± 4.9 years post-transplantation. According to the International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 criteria, three of the six cases (50%) were defined as class I, one was class II, one was class IV, and one was class III + V. The graft and patient survival rates of recurrent lupus nephritis (n = 6) were not different from those of patients with other diagnostic entities. Although recurrent lupus nephritis was not uncommon, it did not appear to have a strong negative impact on long-term outcome in Chinese kidney transplant patients. The recurrence was potentially treatable and should not be precluded for receiving transplantation.
Similar content being viewed by others
References
A report from the ASC/NIH renal transplant registry (1975) Renal transplantation in congenital and metabolic diseases. JAMA 232:148–153
Bunnapradist S, Chung P, Peng A, Hong A, Chung P, Lee B, Fukami S, Takemoto SK, Singh AK (2006) Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database. Transplantation 82:612–618
Stone JH, Amend WJ, Criswell LA (1998) Outcome of renal transplantation in ninety-seven cyclosporine-era patients with systemic lupus erythematosus and matched controls. Arthritis Rheum 41:1438–1445
Grimbert P, Frappier J, Bedrossian J, Legendre C, Antoine C, Hiesse C, Bitker MO, Sraer JD, Lang P (1998) Long-term outcome of kidney transplantation in patients with systemic lupus erythematosus: a multicenter study. Groupe Cooperatif de Transplantation d'Ile de France. Transplantation 66:1000–1003
Ponticelli C, Moroni G (2005) Renal transplantation in lupus nephritis. Lupus 14:95–98
Fujii A, Yamaguchi Y, Horita S, Yumura W, Fuchinoue S, Teraoka S (2006) Early recurrence of lupus nephritis after renal transplantation—a case report. Clin Transplant 20(Suppl 15):42–45
Hariharan S, Peddi VR, Savin VJ, Johnson CP, First MR, Roza AM, Adams MB (1998) Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registry. Am J Kidney Dis 31:928–931
Nyberg G, Blohme I, Persson H, Olausson M, Svalander C (1992) Recurrence of SLE in transplanted kidneys: a follow-up transplant biopsy study. Nephrol Dial Transplant 7:1116–1123
Stone JH, Millward CL, Olson JL, Amend WJ, Criswell LA (1998) Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era. Arthritis Rheum 41:678–686
Goral S, Ynares C, Shappell SB, Snyder S, Feurer ID, Kazancioglu R, Fogo AB, Helderman JH (2003) Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare. Transplantation 75:651–656
Goss JA, Cole BR, Jendrisak MD, McCullough CS, So SK, Windus DW, Hanto DW (1991) Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. A single-center experience and a review of the literature. Transplantation 52:805–810
Weng F, Goral S (2005) Recurrence of lupus nephritis after renal transplantation: if we look for it, will we find it? Nat Clin Pract Nephrol 1:62–63
Burgos PI, Perkins EL, Pons-Estel GJ, Kendrick SA, Liu JM, Kendrick WT et al (2009) Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution. Arthritis Rheum 60:2757–2766
Contreras G, Mattiazzi A, Guerra G, Ortega LM, Tozman EC, Li H et al (2010) Recurrence of lupus nephritis after kidney transplantation. J Am Soc Nephrol 21:1200–1207
Norby GE, Strøm EH, Midtvedt K, Hartmann A, Gilboe IM, Leivestad T, Stenstrøm J, Holdaas H (2010) Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study. Ann Rheum Dis 69:1484–1487
Yu TM, Chen YH, Lan JL, Cheng CH, Chen CH, Wu MJ, Shu KH (2008) Renal outcome and evolution of disease activity in Chinese lupus patients after renal transplantation. Lupus 17:687–694
Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250
Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM et al (2003) Antibody-mediated rejection criteria — an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3:708–714
Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T et al (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713–723
Abrahamowicz M, Fortin PR, du Berger R, Nayak V, Neville C, Liang MH (1998) The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials. J Rheumatol 25:277–284
Herrera GA (1999) The value of electron microscopy in the diagnosis and clinical management of lupus nephritis. Ultrastruct Pathol 23:63–77
Meehan SM, Chang A, Khurana A, Baliga R, Kadambi PV, Javaid B (2008) Pauci-immune and immune glomerular lesions in kidney transplants for systemic lupus erythematosus. Clin J Am Soc Nephrol 3:1469–1478
Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT et al (2005) Mycophenolate mofetil or ntravenous cyclophosphamide for lupus nephritis. N Engl J Med 353(21):2219–2228
Acknowledgements
The authors thank Ms. Chang for statistical assistance and Lin I-Ping for data collection.
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, TM., Wen, MC., Li, CY. et al. Impact of recurrent lupus nephritis on lupus kidney transplantation. Clin Rheumatol 31, 705–710 (2012). https://doi.org/10.1007/s10067-011-1931-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1931-y